Photo-Protection Trial (NB-UVB vs. Placebo) in High-risk Hospitalized COVID-19 Patients

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 21, 2021

Primary Completion Date

October 31, 2021

Study Completion Date

December 1, 2021

Conditions
Covid19Corona Virus InfectionAutoimmune DiseasesCoagulation Disorder, Blood
Interventions
DEVICE

Narrow Band ultraviolet B-Band Light

Daily doses of NB-UVB for 8 consecutive days.

DEVICE

non Narrow Band ultraviolet B-Band Light

Daily doses of non-NB-UVB for 8 consecutive days.

Trial Locations (1)

70112

West Jefferson Medical Center and LSUHSC-NO, New Orleans

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Louisiana State University Health Sciences Center in New Orleans

OTHER

collaborator

Baylor College of Medicine

OTHER

collaborator

West Jefferson Medical Center

UNKNOWN

lead

Cytokind, Inc.

INDUSTRY

NCT04818970 - Photo-Protection Trial (NB-UVB vs. Placebo) in High-risk Hospitalized COVID-19 Patients | Biotech Hunter | Biotech Hunter